Finanzwire Finanzwire
Basculer en Français
10372 Companies
216173 Keywords
145882 Articles
114461 Press releases
Headlines Articles Press releases Protenus, Inc. Remove
  1. Home
  2. Companies
  3. Protenus, Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 02/07/2024 at 15:00, 2 years 3 months ago

    Protenus is Awarded Top-Performing Solutions Vendor in Two Segments for Second Consecutive Year Based on 2024 Best in KLAS Report

    Protenus, a healthcare compliance analytics platform, achieves highest score for patient privacy monitoring and drug diversion surveillance solutions for the second year in a row, as reported by 2024 Best in KLAS: Software & Services. Protenus' AI-driven solutions help healthcare organizations nationwide to proactively identify and prevent privacy data breaches and drug diversion, reducing manual tasks and focusing on better risk-reduction outcomes
    Protenus Healthcare Compliance Analytics Patient Privacy Monitoring Drug Diversion Surveillance Best In KLAS
    Logo of Protenus, Inc.
  • PRESS RELEASE

    published on 10/26/2023 at 14:00, 2 years 6 months ago

    Protenus Granted Fifth New Patent for Drug Diversion Surveillance Technology

    Logo of Protenus, Inc.
  • PRESS RELEASE

    published on 06/22/2023 at 18:00, 2 years 10 months ago

    New 2023 Diversion Digest From Protenus Spotlights the Prevalence of Drug Diversion in Healthcare

    Logo of Protenus, Inc.
  • PRESS RELEASE

    published on 03/08/2023 at 18:00, 3 years 2 months ago

    Protenus Earns Fourth Great Place to Work Certification

    Logo of Protenus, Inc.
Previous page
1 2
Accesswire
  • Published on 05/09/2026 at 01:55, 1 day 1 hour ago

    Prospect Ridge Announces Board Resignation

  • Published on 05/09/2026 at 01:40, 1 day 1 hour ago

    Findev Inc. Issues Corrective Disclosure

  • Published on 05/09/2026 at 01:30, 1 day 1 hour ago

    Star Copper Announces Agreement with Zimtu Capital Corp.

  • Published on 05/09/2026 at 00:00, 1 day 3 hours ago

    Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology

  • Published on 05/08/2026 at 23:01, 1 day 4 hours ago

    Water Ways Announces Corporate Updates

View all ACCESSWIRE
EQS Group
  • Published on 05/09/2026 at 19:05, 8 hours 23 minutes ago

    LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency

  • Published on 05/08/2026 at 20:38, 1 day 6 hours ago

    EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations

  • Published on 05/08/2026 at 19:12, 1 day 8 hours ago

    EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026

  • Published on 05/08/2026 at 19:02, 1 day 8 hours ago

    Metall Zug – Annual General Meeting of Shareholders approves all proposals

  • Published on 05/08/2026 at 18:29, 1 day 9 hours ago

    Designated Person Notification

View all EQS
Les Echos
  • Published on 05/07/2026 at 19:15, 2 days 8 hours ago

    2026 Annual General Meeting: approval of all resolutions submitted to the Meeting

  • Published on 05/07/2026 at 19:06, 2 days 8 hours ago

    Disclosure of Share Capital and Voting Rights as of April 30, 2026

  • Published on 05/07/2026 at 18:17, 2 days 9 hours ago

    DESCRIPTION OF THE LOUIS HACHETTE GROUP SHARE BUYBACK PROGRAM 2026-2027

  • Published on 05/07/2026 at 18:12, 2 days 9 hours ago

    LNA SANTE : Q1 2026

  • Published on 05/07/2026 at 17:45, 2 days 9 hours ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy